Market access strategy to biopharma clients

Led team responsible for the organization's distribution relationship with Brand and Specialty biopharma manufacturers. Drove business development, negotiation, and contracting strategy for all biopharma manufacturers doing business in the US across all therapeutic categories for full-line wholesale, specialty distribution, physician clinic distribution. Represented roughly one-third of brand and specialty pharma volume in the US, approximately $200B in annual buy-side revenue.

Led group responsible for the strategic, value-creating relationship between AmerisourceBergen and Brand and Specialty manufacturers

Strategy creation for Strategic Global Sourcing and drive execution of that strategy across team and throughout the enterprise, acting as liaison to other manufacturer-facing business units and customer teams

Responsible for developing and managing the AmerisourceBergen relationship with large pharmaceutical companies leading and coordinating cross-ABC growth opportunities while building deeper and broader manufacturer relations

• High science start-up commercializing the first proteomic prognostic test available for prostate cancer• Through launch efforts aligned all scientific, operational, reimbursement, and commercial efforts, designing the staged launch process for successful commercial market acceptance

•Creation of new business model, developing suite of consulting services delivered to C-Suite of Large Urology Group Practices•General Consulting and Practice Management Data Consulting•Provide strategic and operational support to group of 6 Vice Presidents who call on C-Suite of Large Urology Group Practices•Integrate account approach across 3 business units (AMS, Endo Pharmaceuticals, HealthTronics) inclusive of Medical Devices, Health IT Solutions, mobilized capital equipment partnerships, and pharmaceuticals

Brand management for REMICADE, largest brand at Johnson & Johnson

Led sales team of 6-10 sales professionals promoting REMICADE and Simponi to rheumatologists in the Greater New York area, approximately $150MM/year in sales

Training and development of 100 member, $800MM Gastroenterology sales force.

Biotech sales representative calling on hospitals and offices, with heavy buy and bill emphasis, in gastroenterology and cardiology.

Primary Care/Specialty/Hospital sales representative calling on cardiologists, rheumatologists, and orthopedic surgeons.